Article Text

Download PDFPDF
Drugs and light for the prevention and treatment of neo-natal jaundice


The enzyme system for conjugating bilirubin is often deficient in neonates, especially the immature. Unconjugated bilirubin is not excreted well, and if the concentration in plasma exceeds about 20 mg/100 ml,1 unbound unconjugated bilirubin may pass the blood-brain barrier2 and cause permanent damage - kernicterus. The treatment of jaundiced infants is aimed at preventing this damage.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.